For many pharmaceutical manufacturing processes, often very old equipment or technology is still being used.
Koligo Therapeutics, a regenerative medicine and 3D bioprinting company, will list on the Australian Securities Exchange at the end of March via an initial public offering.
UK researchers are working to develop drugs that could be given in the first few hours following a heart attack to minimise heart muscle death caused by the stress signals.
Researchers have discovered a potential new pharmaceutical candidate for tuberculosis, finding that the antimicrobial peptide NZX rapidly and effectively kills TB bacteria.
Scientists have developed a nutrient-rich liquid that enables collected horse semen to live for two weeks outside the body without the need to be frozen.
Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies.
Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C.
Researchers have used molecular 'Velcro' to understand how an important protein, RecA, goes about repairing damaged DNA in bacteria.
Statin therapy is safe and effective in older people over 75 years and reduces major vascular events such as heart attacks and strokes, according to new research.
Australian researchers are claiming that shorter courses of antibiotics are nearly always as effective as longer ones for many common infections.
Scientists have engineered a virus that selectively targets and kills cancer cells, with a stronger anticancer effect than another engineered virus currently used in clinical practice.
Australia's Cartherics and Seoul-based ToolGen have teamed up to bring innovative immunotherapies for cancer a step closer to reality.
Growing up in Germany, Melanie Bahlo used to record which birds came and visited her bird feeder in the depths of winter. She was around eight years old at the time and loved discovering new things.
Chemical compounds derived from the cannabis sativa plant, used as an add-on treatment, may help ease symptoms of spasticity in people with motor neuron disease.
A tiny device that electrically stimulates the brain could one day be used to treat conditions such as epilepsy and Parkinson's disease — without open-brain surgery.